Management of Newly Diagnosed Metastatic Carcinoma of the Prostate
Authors:
- Jack S. ElderJEJack S. Elder
- William J. CatalonaWCWilliam J. Catalona
- 1 May 1984
- journal article
- clinical trial
- Published by Elsevier in Urologic Clinics of North America
- Vol. 11 (2) , 283-295
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Carcinoma of the prostate: Clinical and pathological staging and prognosisThe Prostate, 1983
- Risk factors for the development of distant metastases in patients undergoing pelvic lymphadenectomy for prostatic cancerThe American Journal of Surgery, 1982
- Estramustine phosphate with multiple cytotoxic agents in treatment of advanced prostatic cancerUrology, 1981
- Bilateral orchiectomy for carcinoma of prostate Response of serum testosterone and clinical Response to subsequent estrogen therapyUrology, 1981
- Treatment of previously untreated (by hormonal manipulation) stage D adenocarcinoma of prostate with combined orchiectomy, estrogen, and cis diamminedichloroplatinumUrology, 1980
- Interstitial radiation therapy for carcinoma of the prostateThe Prostate, 1980
- Hormone ReceptorsNew England Journal of Medicine, 1979
- Inhibition of testicular luteinizing hormone receptor level by treatment with a potent luteinizing hormone-releasing hormone agonist or human chorionic gonadotropinBiochemical and Biophysical Research Communications, 1977
- Plasma Testosterone: An Accurate Monitor of Hormone Treatment in Prostatic CancerBritish Journal of Urology, 1973
- Selective Retention of Dihydrotestosterone by Prostatic NucleiNature, 1968